Processa Pharmaceuticals Inc expected to post a loss of 28 cents a share - Earnings Preview

Processa Pharmaceuticals

09/05/2023 24:42

* Processa Pharmaceuticals Inc  PCSA.OQ   PCSA.O  is
expected
to report results on May 10 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for Processa
Pharmaceuticals
Inc is for a loss of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Processa
Pharmaceuticals Inc is $4​, above​ its last closing price
of $0.70. ​​​

This summary was machine generated May 8 at 23:42 GMT.  All
figures in US dollars  unless otherwise stated